KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$76.27
Tradestie Score
54
Market Cap
$2.86B
P/E Ratio
79.7
Revenue Growth
0.6%
Analyst Upside
+28.5%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RGC Regencell Bioscience Holdings Limited Ordinary Shares
$5.64
$7.83B - 45 Compare
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$104.71
$6.64B - 62 Compare
KRYS Krystal Biotech, Inc. Common Stock
$347.00
$5.20B 43.3 47 Compare
ALKS Alkermes Inc. plc
$45.97
$5.06B 118.2 59 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$84.95
$3.92B - 46 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$98.22
$3.67B - 59 Compare
LNTH Lantheus Holdings, Inc
$100.25
$3.51B 24.0 46 Compare
SRRK Scholar Rock Holding Corporation Common Stock
$55.41
$3.33B - 43 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$17.01
$3.26B 35.9 52 Compare
PBH Prestige Consumer Healthcare Inc.
$46.95
$3.12B 13.6 36 Compare

Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry